Hypothesis

During wakefulness, calcium influx in calbindin‑poor neurons damages mitochondria and ER, generating ubiquitin‑tagged organelles that are sorted into lysosomal exosomes for extracellular release. The glymphatic system, maximally active during slow‑wave sleep, then clears these exosomes from the interstitial space, preventing their re‑uptake and subsequent seeding of intracellular aggregates. When sleep is disrupted, exosome clearance falls, leading to accumulation of exosome‑associated damaged mitochondria that trigger maladaptive inflammasome activation and promote tau phosphorylation. Calbindin loss exacerbates this cascade by shifting the calcium‑dependent signal from protective PINK1‑Parkin mitophagy to a calcium‑activated calpain pathway that cleaves exosomal cargo (e.g., tau) into aggregation‑prone fragments. Thus, sleep is not merely a passive flush but an active gatekeeper that licenses lysosomal exosome export and subsequent glymphatic removal of waking‑acquired damage.

Testable Predictions

1. Enhancing lysosomal exosome release during sleep rescues neurodegeneration in calbindin‑KO mice. Pharmacological activation of RAB27A or optogenetic stimulation of lysosomal exocytosis specifically during slow‑wave sleep should reduce mitochondrial damage markers (e.g., oxidized cytochrome c) and lower phospho‑tau levels compared with controls.
2. Blocking exosome release exacerbates pathology even with intact sleep. Genetic knockdown of RAB27A or treatment with GW4869 (exosome secretion inhibitor) during sleep will cause interstitial accumulation of exosome‑associated damaged mitochondria, measurable by increased exosomal TOM20 in CSF, and accelerate cognitive decline.
3. Calbindin deficiency redirects calcium signaling from mitophagy to calpain‑dependent exosome cargo cleavage. In calbindin‑deficient neurons, calcium overload will increase calpain activity (detected by calpain‑specific spectrin breakdown products) and reduce PINK1‑Parkin colocalization with mitochondria, while increasing cleaved tau within exosomes.
4. Glymphatic impairment uncouples exosome clearance from sleep. In aged mice with reduced AQP4 polarization, sleep‑induced increases in interstitial space will fail to lower exosome concentration, despite normal exosome release, leading to persistent extracellular organelle load.

Mechanistic Reasoning Beyond the Cited Work

The current model links calcium dysregulation to autophagic and glymphatic failure but does not specify how damaged organelles are handed off to the extracellular clearance system. We propose that lysosomal exosomes serve as the intermediate "damage tags" that are actively loaded during wakefulness and exported in a calcium‑dependent, RAB27A‑regulated manner. Sleep‑dependent glymphatic flow then provides the bulk‑clearance step, analogous to a nightly waste‑collection service that only operates when the city’s streets are quiet. Calbindin loss skews the calcium sensor repertoire, favoring proteases that mutilate exosomal cargo, turning a protective export mechanism into a seed for pathology. This reframes the sleep autopsy as a two‑step quality‑control process: (1) intracellular triage into exosomes, (2) extracellular glymphatic removal. Disruption at either step converts the autopsy into a mis‑filed report, allowing damaged components to persist and propagate neurodegeneration.

Experimental Approach

• Use calbindin‑floxed mice crossed with CamKII‑Cre to delete calbindin in forebrain excitatory neurons.
• Measure mitochondrial ROS, exosomal TOM20, and phospho‑tau in CSF and brain interstitial fluid via microdialysis before and after sleep deprivation.
• Manipulate exosome release with AAV‑shRAB27A or chemogenetic lysosomal exocytosis (e.g., optogenetic lysosomal‑associated membrane protein 1‑ChR2) timed to sleep epochs.
• Assess glymphatic function with intrathecal CSF‑trace tracer (e.g., Evans blue) and two‑photon imaging.
• Behavioral readouts: Morris water maze and fear conditioning.

If enhancing exosome release during sleep normalizes mitochondrial health and prevents tauopathy despite calbindin loss, the hypothesis is supported. Conversely, if blocking exosome release worsens pathology independent of sleep quality, the hypothesis is falsified.

Key References [1] https://pubmed.ncbi.nlm.nih.gov/21874328/ [2] https://gethealthspan.com/science/article/glymphatic-system-autophagy-neurodegenerative-disease-prevention [3] https://pmc.ncbi.nlm.nih.gov/articles/PMC12465791/ [4] https://pmc.ncbi.nlm.nih.gov/articles/PMC11183173/ [5] https://www.scientificarchives.com/article/impact-of-sleep-on-autophagy-and-neurodegenerative-disease-sleeping-your-mind-clear [6] https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2012.00200/full [7] https://pmc.ncbi.nlm.nih.gov/articles/PMC7483964/